Scalper1 News
Specialty drugmaker Allergan (AGN) reported second-quarter profit and sales that beat Wall Street’s estimates Monday and announced that it’s trimming its workforce by 13% as it fends off a hostile takeover bid. The stock rose about 2% in early afternoon trading on the stock market today. Allergan’s Q2 earnings rose 24% over the year-earlier quarter to $1.51 a share, beating analysts’ consensus by 6 cents. It was the fourth straight quarter of Scalper1 News
Scalper1 News